Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Thomas_2009_J.Pharmacol.Exp.Ther_328_556

Reference

Title: Chronic treatment with the dipeptidyl peptidase-4 inhibitor BI 1356 [(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-yl methyl)-3,7-dihydro-purine-2,6-dione] increases basal glucagon-like peptide-1 and improves glycemic control in diabetic rodent models
Thomas L, Tadayyon M, Mark M
Ref: Journal of Pharmacology & Experimental Therapeutics, 328:556, 2009 : PubMed

        



Related information



Citations formats

Thomas L, Tadayyon M, Mark M (2009)
Chronic treatment with the dipeptidyl peptidase-4 inhibitor BI 1356 [(R)-8-(3-amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-yl methyl)-3,7-dihydro-purine-2,6-dione] increases basal glucagon-like peptide-1 and improves glycemic control in diabetic rodent models
Journal of Pharmacology & Experimental Therapeutics 328: 556-63

Thomas L, Tadayyon M, Mark M (2009)
Journal of Pharmacology & Experimental Therapeutics 328: 556-63



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer